SCHEMBL4128706

SCHEMBL4128706

CC(C)(C)OC(=O)NCC1CC1c1ccccc1-c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.42
HTR2C P28335 1/20 0.42
ACACB O00763 3/20 0.40
ACACA Q13085 3/20 0.40
LMNA P02545 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
DRD2 P14416 5/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
GAA P10253 1/20 0.38
MTNR1B P49286 1/20 0.38
BRD4 O60885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4128708 1.00 CNR1 (0.42) CNR1HTR2CACACBACACALMNA
SCHEMBL5312992 0.94 HTR2C (0.39) CNR1HTR2CACACBACACALMNA
SCHEMBL4131902 0.90 HTR2C (0.54) HTR2CACACBACACADRD2SLC6A4
SCHEMBL4131900 0.90 HTR2C (0.54) HTR2CACACBACACADRD2SLC6A4
SCHEMBL4131945 0.88 HTR2C (0.41) HTR2CACACBACACAHTTDRD2
SCHEMBL4131941 0.88 HTR2C (0.41) HTR2CACACBACACAHTTDRD2
SCHEMBL5343070 0.85 HTR2C (0.48) HTR2CACACBACACAMEN1HTT
SCHEMBL5313624 0.83 HTR2C (0.39) HTR2CACACBACACASLC6A4SLC6A3
SCHEMBL4133946 0.83 CNR1 (0.49) CNR1HTR2CACACBACACALMNA
SCHEMBL4133949 0.83 CNR1 (0.49) CNR1HTR2CACACBACACALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-08-13 US disclosed
WO-2007025144-A1 5-HT2C RECEPTOR AGONISTS AS ANORECTIC AGENTS UNIVERSITY OF ILLINOIS - CHICAGO (US) 2007-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents HTR2C, HTR2A, HTR5A CNR1 70/4885HTR2C 1/4885ACACB 1998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.